aTyr Pharma, Inc. (ATYR) vs CervoMed Inc. (CRVO)
A side-by-side comparison of aTyr Pharma, Inc. and CervoMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATYR
aTyr Pharma, Inc.
$0.29HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
CRVO
CervoMed Inc.
$3.21HealthcareDelayed quote: Oct 6, 2026, 12:08 PM EDT
Total return — ATYR vs CRVO
growth of $100 · dividends reinvested · last 2yATYR -83.2% (-59.1%/yr)CRVO -83.0% (-58.7%/yr)CRVO compounded faster over this window
ATYR CRVO
ATYR vs CRVO: by the numbers
- •CRVO is the larger company ($30M vs $29M market cap).
- •Both run net losses; CRVO's is the smaller (-9408.76% vs -32003.68% net margin).
Metrics side by side
Valuation
| Metric | ATYR | CRVO |
|---|---|---|
| P/S ratio | 151.46 | 91.99 |
| P/B ratio | 0.59 | 1.29 |
Profitability
| Metric | ATYR | CRVO |
|---|---|---|
| Gross margin | -717.37% | 0.00% |
| Operating margin | -40856.32% | 0.00% |
| Net margin | -32003.68% | -9408.76% |
| ROE | -124.64% | -132.18% |
| ROIC | -109.29% | -135.73% |
Growth (annualized)
| Metric | ATYR | CRVO |
|---|---|---|
| Revenue CAGR (5Y) | -38.74% | N/A |
| Total return CAGR (5Y) | N/A | -38.25% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.